Edmond de Rothschild Holding’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Edmond de Rothschild Holding’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,667	Closed	-$15.2K	–	765
2023 Q1	$15.2K	Hold	1,667	–	–	﹤0.01%	668
2022 Q4	$19.6K	Hold	1,667	–	–	﹤0.01%	719
2022 Q3	$35K	Buy	+1,667	New	+$44.9K	﹤0.01%	700
2022 Q2	–	Sell	-1,667	Closed	-$83K	–	888
2022 Q1	$83K	Hold	1,667	–	–	﹤0.01%	610
2021 Q4	$117K	Hold	1,667	–	–	﹤0.01%	610
2021 Q3	$156K	Hold	1,667	–	–	﹤0.01%	573
2021 Q2	$168K	Hold	1,667	–	–	﹤0.01%	556
2021 Q1	$156K	Buy	+1,667	New	+$169K	﹤0.01%	510

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Edmond de Rothschild Holding's VBIV Position: Q2 2023 in Review

Edmond de Rothschild Holding sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 1,667 shares — an estimated $15.2K sold.

Edmond de Rothschild Holding first reported a position in VBIV in Q1 2021 and held it in 8 quarters. The position peaked at $168K in Q2 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

Edmond de Rothschild Holding reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
Edmond de Rothschild Holding sold 1,667 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $15.2K.
Edmond de Rothschild Holding first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2021 and held it in 8 quarters.
Edmond de Rothschild Holding's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $168K in Q2 2021.
46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2023, filed 9 Aug 2023.